Observational studyInternational ophthalmology2026
Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting.
Observational study in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeWe evaluated outcomes associated with argon laser demarcation of cytomegalovirus (CMV) retinitis lesions to prevent retinal detachments amongst people with AIDS in a resource-poor setting.
methodsWe performed a retrospective, longitudinal, observational cohort study of patients with AIDS-related CMV retinitis who were treated with laser demarcation to prevent retinal detachment during a 4-year period at a single facility in Yangon, Myanmar. The main outcomes were retinal detachment and loss of central visual acuity. We also evaluated a comparator group of patients who presented with AIDS-related CMV retinitis and concomitant retinal detachment.
resultsLaser demarcation was performed on 45 eyes (38 patients). All were receiving combination antiretroviral therapy (cART). All treated eyes had inactive CMV retinitis lesions involving ≥ 25% of the retinal area. No eye developed a retinal detachment or loss of central visual acuity during follow-up for 3 years. In contrast, eyes that presented with retinal detachments that were surgically repaired experienced further loss of vision (6 of 14 eyes [42%]) and recurrent detachments (4 of 14 eyes [28.6%]).
conclusionsAlthough laser demarcation of CMV retinitis lesions is not routinely performed in geographic regions where patients can be followed closely and have access to vitreoretinal surgeons, the procedure may be useful for some patients in resource-limited settings.
Indexed as
Identifiers
41854912What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.